The DOI matches its Crossref record; 167 of the 173 references it cites were found in a registry or an index.
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Open accessAbstract
BACKGROUND: Antibiotics are widely prescribed; however they can cause disturbances in gastrointestinal flora which may lead to reduced resistance to pathogens such as Clostridium difficile (C. difficile). Probiotics are live organisms thought to balance the gastrointestinal flora. OBJECTIVES: The primary objectives were to assess the efficacy and safety of probiotics for preventing Clostridium difficile-associated diarrhea (CDAD) or C. difficile infection in adults and children. SEARCH METHODS: On February 21, 2013 we searched PubMed (1966-2013), EMBASE (1966-2013), Cochrane Central Register of Controlled Trials (The Cochrane Library 2013, Issue 1), CINAHL (1982-2013), AMED (1985-2013), and ISI Web of Science. Additionally, we conducted an extensive grey literature search including contact with industry representatives. SELECTION CRITERIA: Randomized controlled (placebo, alternative prophylaxis, or no treatment control) trials investigating probiotics (any strain, any dose) for prevention of CDAD, or C. difficile infection were considered for inclusion. DATA COLLECTION AND ANALYSIS: Two authors independently and in duplicate extracted data and assessed risk of bias using pre-constructed, and piloted, data extraction forms. Any disagreements were resolved by a third adjudicator. For articles published in abstract form only, further information was sought by contacting principal authors. The primary outcome was the incidence of CDAD. Secondary outcomes included the incidence of C. difficile infection, adverse events, antibiotic-associated diarrhea (AAD) and length of hospital stay. Dichotomous outcomes (e.g. incidence of CDAD) were pooled using a random-effects model to calculate the relative risk and corresponding 95% confidence interval (95% CI). Continuous outcomes (e.g. length of hospital) were pooled using a random-effects model to calculate the mean difference and corresponding 95% CI. Sensitivity analyses were conducted to explore the impact of missing data on efficacy and safety outcomes. For the sensitivity analyses, we assumed that the event rate for those participants in the control group who had missing data was the same as the event rate for those participants in the control group who were successfully followed. For the probiotic group we calculated effects using the following assumed ratios of event rates in those with missing data in comparison to those successfully followed: 1.5:1, 2:1, 3:1, and 5:1. To explore possible explanations for heterogeneity, a priori subgroup analysis were conducted on probiotic species, dose, adult versus pediatric population, and risk of bias.The overall quality of the evidence supporting each outcome was assessed using the GRADE criteria. MAIN RESULTS: A total of 1871 studies were identified with 31 (4492 participants) meeting eligibility requirements for our review. Overall 11 studies were rated as a high risk of bias due mostly to missing outcome data. A complete case analysis (i.e. participants who completed the study) of those trials investigating CDAD (23 trials, 4213 participants) suggests that probiotics significantly reduce this risk by 64%. The incidence of CDAD was 2.0% in the probiotic group compared to 5.5% in the placebo or no treatment control group (RR 0.36; 95% CI 0.26 to 0.51). Sixteen of 23 trials had missing CDAD data ranging from 5% to 45%. These results proved robust to sensitivity analyses of plausible and worst-plausible assumptions regarding missing outcome data and were similar whether considering trials in adults versus children, lower versus higher doses, different probiotic species, or higher versus lower risk of bias. Our judgment is that the overall evidence warrants moderate confidence in this large relative risk reduction. We downgraded the overall quality of evidence for CDAD to 'moderate' due to imprecision. There were few events (154) and the calculated optimal information size (n = 8218) was more than the total sample size. With respect to the incidence of C. difficile infection, a secondary outcome, pooled complete case results from 13 trials (961 participants) did not show a statistically significant reduction. The incidence of C. difficile infection was 12.6% in the probiotics group compared to 12.7% in the placebo or no treatment control group (RR 0.89; 95% CI 0.64 to 1.24). Adverse events were assessed in 26 studies (3964 participants) and our pooled complete case analysis indicates probiotics reduce the risk of adverse events by 20% (RR 0.80; 95% CI 0.68 to 0.95). In both treatment and control groups the most common adverse events included abdominal cramping, nausea, fever, soft stools, flatulence, and taste disturbance. For the short-term use of probiotics in patients that are not immunocompromised or severely debilitated, we consider the strength of this evidence to be moderate. AUTHORS' CONCLUSIONS: Based on this systematic review and meta-analysis of 23 randomized controlled trials including 4213 patients, moderate qua
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Goldenberg and coworkers (113) concluded, after an exhaustive meta-analysis (23 clinical trials, n = 4,213), that there is moderate evidence suggesting that probiotics are effective in the prevention of CDAD.”
From Bifidobacteria and Their Health-Promoting Effects (2017) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationConducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
(2008) · Cited by 3,790
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538
Publication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282
Flagged first, then by citations
6 of the 173 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Benhamou, 1999, Antibiotic-associated diarrhoea in children: A computer monitored double-blind outpatients trial comparing a protective and a probiotic agent, Medecine et Chirurgie Digestives, 28, 163
- Plewinska, 2006, Probiotics in the treatment of Helicobacter pylori infection in children, Gastroenterologia Polska, 13, 315
- Potts, 1996, Randomised double blind placebo controlled study of the ability of saccharomyces boulardii to prevent antibiotic related diarrhoea, Gut, 38 Suppl 1, A61
- Schrezenmeir, 2002, Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections, American Journal of Clinical Nutrition, 75, 400S
- The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan). Version 5.2 2012
Cited by
Sorted by citations
Items 101–200 of 736
The vermiform appendix: an immunological organ sustaining a microbiome inoculum
Vitetta, L., Chen, J., & Clarke, S. J. (2019) · Clinical Science · doi:10.1042/cs20180956 · Cited by 104
Probiotics in Pediatrics. A Review and Practical Guide
Depoorter, L., & Vandenplas, Y. (2021) · Nutrients · doi:10.3390/nu13072176 · Cited by 112
“However, this Cochrane review failed to recommend specific strains and does therefore not help to clinical decision making because some strains resulted in a favorable effect while others did not [35].”
BackgroundInfluentialLaue, C., Papazova, E., Liesegang, A., Pannenbeckers, A., Arendarski, P., Linnerth, B., Domig, K. J., Kneifel, W., Petričević, L., & Schrezenmeir, J. (2017) · Beneficial Microbes · doi:10.3920/bm2017.0018 · Cited by 101
Probiotics and vaginal microecology: fact or fancy?
Buggio, L., Somigliana, E., Borghi, A., & Vercellini, P. (2019) · BMC Women s Health · doi:10.1186/s12905-019-0723-4 · Cited by 101
“Their consumption has been proven effective for the management of some gastrointestinal conditions, such as irritable bowel syndrome, and for the prevention of diarrhoea associated with Clostridium difficile infection [3, 4].”
BackgroundProbiotics and prebiotics: prospects for public health and nutritional recommendations
Sanders, M. E., Lenoir‐Wijnkoop, I., Salminen, S., Merenstein, D. J., Gibson, G. R., Petschow, B. W., Nieuwdorp, M., Tancredi, D. J., Cifelli, C. J., Jacques, P. F., et al. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12377 · Cited by 108
Agamennone, V., Krul, C. A. M., Rijkers, G. T., & Kort, R. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0831-x · Cited by 104
Clostridium difficile infection in the twenty-first century
Ghose, C. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.62 · Cited by 101
Gut barrier dysfunction and microbial translocation in cancer cachexia
Klein, G. L., Petschow, B. W., Shaw, A. L., & Weaver, E. M. (2013) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000017 · Cited by 95
Shaping Microbiota During the First 1000 Days of Life
Selma‐Royo, M., Tarrazó, M., García‐Mantrana, I., Gómez-Gallego, C., Salminen, S., & Collado, M. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_312 · Cited by 98
Use of probiotics and prebiotics in infant feeding
Bertelsen, R. J., Jensen, E. T., & Ringel‐Kulka, T. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.01.001 · Cited by 93
Plaza‐Díaz, J., Ruiz‐Ojeda, F. J., Gil‐Campos, M., & Gil, Á. (2018) · Nutrients · doi:10.3390/nu10010042 · Cited by 100
Probiotics, D–Lactic acidosis, oxidative stress and strain specificity
Vitetta, L., Coulson, S., Thomsen, M., Nguyen, T. T., & Hall, S. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1279379 · Cited by 87
Probiotics: Current Landscape and Future Horizons
Day, R. L., Harper, A. J., Woods, R. M., Davies, O. G., & Heaney, L. M. (2019) · Future Science OA · doi:10.4155/fsoa-2019-0004 · Cited by 92
Strategies to PreventClostridium difficileInfections in Acute Care Hospitals: 2014 Update
Dubberke, E. R., Carling, P., Carrico, R., Donskey, C. J., Loo, V. G., McDonald, L. C., Maragakis, L. L., Sandora, T. J., Weber, D. J., Yokoe, D. S., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1017/s0899823x00193857 · Cited by 85
The effects of proton pump inhibitors on the microbiome in young children
Levy, E. I., Hoang, D. M., & Vandenplas, Y. (2020) · Acta Paediatrica · doi:10.1111/apa.15213 · Cited by 84
The Importance of the Microbiome in Critically Ill Patients: Role of Nutrition
Morón, R., Gálvez, J., Colmenero, M., Anderson, P. O., Barrera, J. C., & Rodríguez‐Cabezas, M. E. (2019) · Nutrients · doi:10.3390/nu11123002 · Cited by 85
Louh, I. K., Greendyke, W. G., Hermann, E. A., Davidson, K. W., Falzon, L., Vawdrey, D. K., Shaffer, J. A., Calfee, D. P., Furuya, E. Y., & Ting, H. H. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2016.324 · Cited by 82
Probiotics in the next-generation sequencing era
Suez, J., Zmora, N., & Elinav, E. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1586039 · Cited by 85
Clostridium difficile Infection in the Elderly
Keller, J. M., & Surawicz, C. M. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.10.008 · Cited by 82
Probiotic and synbiotic safety in infants under two years of age
van den Nieuwboer, M., Claassen, E., Morelli, L., Guarner, F., & Brummer, R. J. (2014) · Beneficial Microbes · doi:10.3920/bm2013.0046 · Cited by 78
“Additionally, meta-analyses indicate that probiotic supplementation results in a reduction in diarrhoeal duration as well as a reduced incidence of Clostridium difficile induced diarrhoea (Goldenberg et al., 2013; Sanders et al., 2013).”
The role of the microbiota in the management of intensive care patients
Szychowiak, P., Villageois-Tran, K., Patrier, J., Timsit, J., & Ruppé, É. (2022) · Annals of Intensive Care · doi:10.1186/s13613-021-00976-5 · Cited by 86
Bishop, E. J., & Tiruvoipati, R. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac404 · Cited by 92
Anderson, J. L., Miles, C. N., & Tierney, A. C. (2016) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2016.09.004 · Cited by 77
Seekatz, A. M., Safdar, N., & Khanna, S. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221134396 · Cited by 84
The role of the microbiome in gastrointestinal inflammation
Sanders, D. J., Inniss, S., Sebepos‐Rogers, G., Rahman, F. Z., & Smith, A. M. (2021) · Bioscience Reports · doi:10.1042/bsr20203850 · Cited by 82
Association of polymicrobial interactions with dental caries development and prevention
Zhu, Y., Wang, Y., Zhang, S., Li, J., Li, X., Ying, Y., Yuan, J., Chen, K., Deng, S., & Wang, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1162380 · Cited by 88
Andermann, T. M., Rezvani, A. R., & Bhatt, A. S. (2016) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-016-0302-9 · Cited by 78
The role of gut microbiota in Clostridium difficile infection
Samarkos, M., Mastrogianni, E., & Kampouropoulou, O. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.02.006 · Cited by 75
Antibiotic-perturbed microbiota and the role of probiotics
Szajewska, H., Scott, K. P., de Meij, T. G. J., Forslund, S. K., Knight, R. D., Koren, O., Little, P. S., Johnston, B. C., Łukasik, J., Suez, J., et al. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-01023-x · Cited by 80
Self-citationSheyholislami, H., & Connor, K. L. (2021) · Nutrients · doi:10.3390/nu13072382 · Cited by 75
Probiotics to Prevent Clostridium difficile Infection in Patients Receiving Antibiotics
Goldenberg, J. Z., Mertz, D., & Johnston, B. C. (2018) · JAMA · doi:10.1001/jama.2018.9064 · Cited by 74
Self-citationThe growth potential for dairy probiotics
Reid, G. (2015) · International Dairy Journal · doi:10.1016/j.idairyj.2015.04.004 · Cited by 81
Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy
Shirley, D.-A. T., Tornel, W., Warren, C. A., & Moonah, S. N. (2023) · PEDIATRICS · doi:10.1542/peds.2023-062307 · Cited by 78
Antiamoebic drugs for treating amoebic colitis
Gonzales, M. L. M., Dans, L. F., & Sio-Aguilar, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006085.pub3 · Cited by 72
“Reviews on the efficacy of probiotics support clinical benefit in preventing Clostridium difficile-associated diarrhoea (Goldenberg 2013), as well as in reducing the duration and severity of acute infectious diarrhoea in children (Allen 2010).”
Slattery, J. M., MacFabe, D. F., & Frye, R. E. (2016) · Clinical Medicine Insights Pediatrics · doi:10.4137/cmped.s38338 · Cited by 72
Caporilli, C., Giannì, G., Grassi, F., & Esposito, S. (2023) · Nutrients · doi:10.3390/nu15102341 · Cited by 69
Ehrhardt, S., Guo, N., Hinz, R., Schoppen, S., May, J., Reiser, M., Schroeder, M. P., Schmiedel, S., Keuchel, M., Reisinger, E. C., et al. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw011 · Cited by 69
Recent advances in modulating the microbiome
Quigley, E. M. M., & Gajula, P. (2020) · F1000Research · doi:10.12688/f1000research.20204.1 · Cited by 69
The Role of Probiotics and Their Metabolites in the Treatment of Depression
Jach, M. E., Serefko, A., Szopa, A., Sajnaga, E., Golczyk, H., Santos, L. S., Borowicz, K. K., & Sieniawska, E. (2023) · Molecules · doi:10.3390/molecules28073213 · Cited by 75
Gonzales-Luna, A. J., Carlson, T. J., & Garey, K. W. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2223345 · Cited by 67
Miles-Jay, A., Snitkin, E. S., Lin, M. Y., Shimasaki, T., Schoeny, M. E., Fukuda, C., Dangana, T. E., Moore, N. M., Sansom, S. E., Yelin, R. D., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02549-4 · Cited by 66
Martindale, R. G., & Deveney, C. W. (2013) · Surgical Clinics of North America · doi:10.1016/j.suc.2013.06.015 · Cited by 70
Wolfe, T. J. D., Eggers, S. I., Barker, A., Kates, A., Dill‐McFarland, K. A., Suen, G., & Safdar, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204253 · Cited by 69
Komala, M. G., Ong, S. G., Qadri, M. U., Elshafie, L. M., Pollock, C. A., & Saad, S. (2023) · Foods · doi:10.3390/foods12020427 · Cited by 66
Haghighat, L., & Crum‐Cianflone, N. F. (2015) · International Journal of STD & AIDS · doi:10.1177/0956462415590725 · Cited by 65
“Further, most guidelines do not recommend probiotics among immunocompromised or severely debilitated persons.(4) Are probiotics safe among immunosuppressed persons? There have been case reports linking probiotic use with invasive Lactobacillus infections among immunosuppressed persons.”
BackgroundA few of our favorite unconfirmed ideas
Marini, J. J., Gattinoni, L., İnce, C., Kozek‐Langenecker, S. A., Mehta, R. L., Pichard, C., Westphal, M., Wischmeyer, P. E., & Vincent, J. (2015) · Critical Care · doi:10.1186/cc14719 · Cited by 65
Protective Effects of Bifidobacterial Strains Against Toxigenic Clostridium difficile
Wei, Y., Yang, F., Wu, Q., Gao, J., Liu, W., Liu, C., Guo, X., Suwal, S., Kou, Y., Zhang, B., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00888 · Cited by 65
Pathway to Prevention of Nosocomial Clostridium difficile Infection
Goldstein, E. J. C., Johnson, S., Maziade, P.-J., McFarland, L. V., Trick, W. E., Dresser, L., Millette, M., Mazloum, H., & Low, D. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ142 · Cited by 64
McFarland, L. V., Ship, N. J., Auclair, J., & Millette, M. (2018) · Journal of Hospital Infection · doi:10.1016/j.jhin.2018.04.017 · Cited by 69
Dental Disease and Periprosthetic Joint Infection
Young, H. L., Hirsh, J. M., Hammerberg, E. M., & Price, C. S. (2014) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.l.01379 · Cited by 63
Mawad, A. M. M., Helmy, Y. A., Shalkami, A. S., Kathayat, D., & Rajashekara, G. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9417-3 · Cited by 63
Recommendations for Probiotic Use in Humans—A 2014 Update
Floch, M. H. (2014) · Pharmaceuticals · doi:10.3390/ph7100999 · Cited by 65
Prevention of Clostridium difficile Infection With Probiotics
Evans, C. T., & Johnson, S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ138 · Cited by 62
Merenstein, D. J., Fraser, C. M., Roberts, R., Liu, T., Grant-Beurmann, S., Tan, T., Smith, K. H., Cronin, T., Martin, O. A., Sanders, M. E., et al. (2021) · Nutrients · doi:10.3390/nu13082814 · Cited by 66
Human Milk Microbiome—A Review of Scientific Reports
Dombrowska-Pali, A., Wiktorczyk-Kapischke, N., Chrustek, A., Olszewska-Słonina, D. M., Gospodarek-Komkowska, E., & Socha, M. W. (2024) · Nutrients · doi:10.3390/nu16101420 · Cited by 74
The Role of the gut Microbiome in the Pathogenesis and Treatment of Obesity
Okeke, F. C., Roland, B. C., & Mullin, G. E. (2014) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2014.018 · Cited by 63
Sleeping with the enemy: Clostridium difficile infection in the intensive care unit
Prechter, F., Katzer, K., Bauer, M. W., & Stallmach, A. (2017) · Critical Care · doi:10.1186/s13054-017-1819-6 · Cited by 61
Exploring the Probiotic Potential of Bacteroides spp. Within One Health Paradigm
Tufail, M. A., & Schmitz, R. A. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10370-9 · Cited by 65
Johnson, S. W., Brown, S. V., & Priest, D. H. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz966 · Cited by 61
Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
Airola, C., Severino, A., Porcari, S., Fusco, W. G., Mullish, B. H., Gasbarrini, A., Cammarota, G., Ponziani, F. R., & Ianiro, G. (2023) · Antibiotics · doi:10.3390/antibiotics12050868 · Cited by 68
Zheng, C., Chen, T., Lu, J., Wei, K., Tian, H., Liu, W., Tian, X., Wang, X., Wang, S., Yang, R. L., et al. (2021) · Food & Function · doi:10.1039/d1fo01375k · Cited by 59
van Dorst, J. M., Tam, R. Y., & Ooi, C. Y. (2022) · Nutrients · doi:10.3390/nu14030480 · Cited by 65
Review of the role of probiotics in gastrointestinal diseases in adults
Domingo, J. J. S. (2017) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2016.12.001 · Cited by 60
Probiotics for oral and vulvovaginal candidiasis: A review
Shenoy, A., & Gottlieb, A. B. (2019) · Dermatologic Therapy · doi:10.1111/dth.12970 · Cited by 82
Fu, Y., Moscoso, D. I., Porter, J., Krishnareddy, S., Abrams, J. A., Seres, D. S., Chong, D. H., & Freedberg, D. E. (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1682 · Cited by 59
The role of the bacterial microbiome in the treatment of cancer
Yu, Z., Xie, R., You, R., Liu, Y., Chen, X.-Y., Chen, M., & Huang, P.-Y. (2021) · BMC Cancer · doi:10.1186/s12885-021-08664-0 · Cited by 57
The Role of Prebiotics and Probiotics in Gastrointestinal Disease
Floch, M. H. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.09.011 · Cited by 60
Pre-, pro- and synbiotics in cancer prevention and treatment—a review of basic and clinical research
Scott, A. J., Merrifield, C. A., Younes, J. A., & Pekelharing, E. P. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.869 · Cited by 59
Bilal, M., Ashraf, S., & Zhao, X. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.931458 · Cited by 58
de la Rosa, D., López-Campos, J. L., Navarrete, B. A., Rubio, M. C., Moreno, R. C., Rivero, J. L. G., Carro, L. M., Fuster, C. O., Martínez‐García, M. Á., Callejas, F. J., et al. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2020.04.023 · Cited by 56
Kujawa-Szewieczek, A., Adamczak, M., Kwiecień, K., Dudzicz, S., Gazda, M., & Więcek, A. (2015) · Nutrients · doi:10.3390/nu7125526 · Cited by 57
Alberda, C., Marcushamer, S., Hewer, T., Journault, N., & Kutsogiannis, D. J. (2018) · Nutrients · doi:10.3390/nu10050539 · Cited by 57
“These results were confirmed by a 2017 systematic review [14].”
BackgroundResultTargeting Gut Microbial Biofilms—A Key to Hinder Colon Carcinogenesis?
Chew, S.-S., Tan, L. T., Law, J. W., Pusparajah, P., Goh, B. H., Mutalib, N. A., & Lee, L. (2020) · Cancers · doi:10.3390/cancers12082272 · Cited by 61
The Probiotic Conundrum: Regulatory Confusion, Conflicting Studies, and Safety Concerns
Freedman, S. B., Schnadower, D., & Tarr, P. I. (2020) · JAMA · doi:10.1001/jama.2019.22268 · Cited by 55
Microbe–microbe interactions during Clostridioides difficile infection
Abbas, A. A., & Zackular, J. P. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.01.016 · Cited by 58
Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury
Johns, J. S., Krogh, K., Rodriguez, G. M., Eng, J. J., Haller, E., Heinen, M., Laredo, R., Longo, W. E., Montero-Colon, W., Wilson, C. S., et al. (2021) · Topics in Spinal Cord Injury Rehabilitation · doi:10.46292/sci2702-75 · Cited by 57
Clostridium difficile, the Difficult “Kloster” Fuelled by Antibiotics
Dicks, L. M. T., Mikkelsen, L. S., Brandsborg, E., & Marcotte, H. (2018) · Current Microbiology · doi:10.1007/s00284-018-1543-8 · Cited by 56
Balsells, E., Filipescu, T., Kyaw, M. H., Wiuff, C., Campbell, H., & Nair, H. (2016) · Journal of Global Health · doi:10.7189/jogh.06.020410 · Cited by 55
Practice Parameters for the Management of Clostridium difficile Infection
Steele, S. R., McCormick, J., Melton, G. B., Paquette, I. M., Rivadeneira, D. E., Stewart, D. A., Buie, W. D., & Rafferty, J. L. (2014) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000289 · Cited by 54
Spaggiari, G., Brigante, G., Vincentis, S. D., Cattini, U., Roli, L., Santis, M. C. D., Baraldi, E., Tagliavini, S., Varani, M., Trenti, T., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00316 · Cited by 57
Revisiting the intestinal microbiome and its role in Diarrhea and constipation
Iancu, M. A., Profir, M., Roşu, O. A., Ionescu, R. F., Cretoiu, S. M., & Gaspar, B. S. (2023) · Microorganisms · doi:10.3390/microorganisms11092177 · Cited by 53
Long-term effects of antimicrobial drugs on the composition of the human gut microbiota
Mulder, M., Radjabzadeh, D., Jong, J. C. K., Uitterlinden, A. G., Kraaij, R., Stricker, B. H. C., & Verbon, A. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1791677 · Cited by 58
“associated diarrhea in not-immunocompromised individuals with a high baseline risk.(22) Furthermore, in mice concurrent probiotics treatment during or after antibiotic therapy caused suppression of Enterobacteriaceae outgrowth, while promoting blooming of Firmicutes.”
BackgroundAutomated Lay Language Summarization of Biomedical Scientific Reviews
Guo, Y., Qiu, W., Wang, Y., & Cohen, T. (2021) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v35i1.16089 · Cited by 61
Eosinophils, probiotics, and the microbiome
Rosenberg, H. F., Masterson, J. C., & Furuta, G. T. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri0416-202r · Cited by 53
Probiotics for people with cystic fibrosis
Coffey, M. J., Garg, M., Homaira, N., Jaffé, A., & Ooi, C. Y. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012949.pub2 · Cited by 58
“Probiotics have also been beneficial in managing Clostridium di#icile infections (Goldenberg 2013) and antibiotic-associated diarrhoea (Goldenberg 2015) as well as preventing acute upper respiratory tract infections (Hao 2015).”
BackgroundProbiotic and synbiotic therapy in the critically ill: State of the art
Davison, J. M., & Wischmeyer, P. E. (2018) · Nutrition · doi:10.1016/j.nut.2018.07.017 · Cited by 54
Majeed, M. A., Majeed, S., Nagabhushanam, K., Arumugam, S., Beede, K., & Ali, F. H. M. (2018) · Food Research International · doi:10.1016/j.foodres.2018.12.003 · Cited by 53
Prophylactic use of probiotics for gastrointestinal disorders in children
Perceval, C. J., Szajewska, H., Indrio, F., Weizman, Z., & Vandenplas, Y. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(19)30182-8 · Cited by 53
The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation
Gibson, C. M., Childs‐Kean, L. M., Naziruddin, Z., & Howell, C. K. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13397 · Cited by 54
Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals
Yi, S. H., Jernigan, J. A., & McDonald, L. C. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.12.001 · Cited by 52
Johnston, B. C., Lytvyn, L., Lo, C. K.-F., Allen, S. J., Wang, D., Szajewska, H., Miller, M., Ehrhardt, S., Sampalis, J., Duman, D. G., et al. (2018) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2018.84 · Cited by 50
Self-citationVernaya, M., McAdam, J. L., & Hampton, M. D. (2017) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2016-003234 · Cited by 51
Fecal transplant policy and legislation
Vyas, D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i1.6 · Cited by 52
Glanville, J., King, S., Guarner, F., Hill, C., & Sanders, M. E. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0004-5 · Cited by 51
Common Gastrointestinal Infections
Sell, J. K., & Dolan, B. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2018.05.008 · Cited by 51
Sales, A. L., DePaula, J., Silva, C. M., da Cruz, A. G., Miguel, M. A. L., & Farah, A. (2020) · Food & Function · doi:10.1039/c9fo02589h · Cited by 55
Duffy, L. C., Raiten, D. J., Hubbard, V. S., & Starke-Reed, P. E. (2015) · Journal of Nutrition · doi:10.3945/jn.114.194936 · Cited by 54
Jiang, Y., & Fan, L. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113456 · Cited by 49
Xie, C., Li, J., Wang, K., Li, Q., & Chen, D. (2015) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2015.03.001 · Cited by 49
Blaze, J. (2021) · INNOVATIONS in pharmacy · doi:10.24926/iip.v12i2.3694 · Cited by 48
Metadata
- Authors
- Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C.
- Affiliations
- Bastyr University (US)
- McMaster University; Division of Plastic & Reconstructive Surgery; 1200 Main Street West - HSC 4E9 Hamilton Ontario Canada L8N 3Z5
- Nasjonalt Kunnskapssenter for Helsetjenesten (NO)
- McMaster University (CA)
- University of Toronto (CA)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-05-31
- Volume
- 12
- Issue
- 5
- Pages
- CD006095-CD006095
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC6486212
- OpenAlex
- W1505136191
- Cited by
- 741
- References
- 173
- Citations by year
- 2026: 1 · 2025: 12 · 2024: 42 · 2023: 60 · 2022: 54 · 2021: 74 · 2020: 79 · 2019: 85 · 2018: 80 · 2017: 65 · 2016: 54 · 2015: 59 · 2014: 51 · 2013: 20
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Update notices
- new_version (2017-12-19)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UTS ePRESS (University of Technology Sydney) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, Clostridium difficile, Clostridium difficile-associated diarrhea, Clostridium difficile infection, antibiotic-associated diarrhea, antibiotic prophylaxis, gut microbiota, length of hospital stay, adverse events, children, adults, probiotic safety, probiotic efficacy, risk of bias, heterogeneity, subgroup analysis, risk of bias assessment
- MeSH terms
- Adult, Anti-Bacterial Agents, Child, Diarrhea, Enterocolitis, Pseudomembranous, Humans, Randomized Controlled Trials as Topic, Clostridioides difficile, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
